Bank of Montreal
BMY.RT

Bank of Montreal’s Bristol-Myers Squibb Company Contingent Value Rights BMY.RT Stock Holding History

Bank of Montreal’s Portfolio BMY.RT Stock Details BMY.RT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-35,097
Closed -$24K – 5518
2020
Q4 		$24K Sell
35,097
-5,452
-13% -$11.6K ﹤0.01% 4349
2020
Q3 		$109K Sell
40,549
-8,140
-17% -$23.2K ﹤0.01% 3032
2020
Q2 		$161K Sell
48,689
-3,847
-7% -$13.9K ﹤0.01% 2840
2020
Q1 		$202K Sell
52,536
-12,216
-19% -$40.2K ﹤0.01% 2325
2019
Q4 		$194K Buy
+64,752
New +$168K ﹤0.01% 3177

Other funds holding BMY.RT

JCI
Jet Capital Investors New York $51M AUM 48.01% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return
BC
Brookfield Corp Toronto, Ontario, Canada $74.2B AUM 0.68% 1-Year Est. Return
TNB
Thomasville National Bank Thomasville, Georgia $1.82B AUM
WAM
Westport Asset Management Southport, Connecticut $226M AUM 16.76% 1-Year Est. Return
IAIM
International Assets Investment Management Orlando, Florida $1.67B AUM 28.26% 1-Year Est. Return

Bank of Montreal's BMY.RT Position: Q1 2021 in Review

Bank of Montreal sold out of Bristol-Myers Squibb Company Contingent Value Rights (BMY.RT) in Q1 2021, closing a stake of 35,097 shares — an estimated $24K sold.

Bank of Montreal first reported a position in BMY.RT in Q4 2019 and held it in 5 quarters. The position peaked at $202K in Q1 2020. 12 funds tracked by Wall St. Rank hold BMY.RT as of Q1 2021.

  • Bank of Montreal reported no remaining Bristol-Myers Squibb Company Contingent Value Rights position as of Q1 2021 after selling out during the quarter.
  • Bank of Montreal sold 35,097 Bristol-Myers Squibb Company Contingent Value Rights shares in Q1 2021, an estimated $24K.
  • Bank of Montreal first reported a position in Bristol-Myers Squibb Company Contingent Value Rights in Q4 2019 and held it in 5 quarters.
  • Bank of Montreal's Bristol-Myers Squibb Company Contingent Value Rights position peaked at $202K in Q1 2020.
  • 12 funds tracked by Wall St. Rank held Bristol-Myers Squibb Company Contingent Value Rights as of Q1 2021.

Based on Bank of Montreal's 13F filing for Q1 2021, filed 13 May 2021.